The prevalence of schizophrenia, affecting approximately 1% of the global population,
underscores the urgency for innovative therapeutic strategies. Recent insights into the role …

Alzheimer's disease (AD) and schizophrenia (SCZ) represent two major neuropathological
conditions with a high disease burden. Despite their distinct etiologies, patients suffering …

Mental disorders are the leading contributors to the globally nonfatal burden of disease. This
study was aimed to estimate the burden of mental disorders in Asian countries. Based on …

Background Based on epidemiological reports, severe mental illness (SMI) and breast
cancer (BC) risk are linked positively. However, it is susceptible to clinical confounding …

How has schizophrenia, a condition that significantly reduces an individual's evolutionary
fitness, remained common across generations and cultures? Numerous theories about the …

Schizophrenia ranks as the third-most common cause of disability among mental disorders
globally. This study presents findings on the prevalence, incidence and years lived with …

Background: Sub-optimal response in schizophrenia is frequent, warranting augmentation
strategies over treatment-as-usual (TAU). Methods: We assessed nutraceuticals …

Functions of the cerebellar cortex, from motor learning to emotion and cognition, depend on
the appropriate molecular composition at diverse synapse types. Glutamate receptor …

The epidemiology of schizophrenia has been reported in many countries. However, due to
the limitations of those studies, the findings cannot be generalized to other parts of the world …

Background Abortion behaviors among individuals with mental disorders presented major
obstacles to women's health. However, few studies reported the prevalence and associated …